Form D · Other Health Care
ProxsysRx, Inc.
Birmingham, AL · CIK 0001833548
Offering snapshot reported Nov 25, 2020 · SEC filing
- Reported sold
- $14.6M Offering amount: $14.6M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 4, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 25, 2020 | Initial | $14,573,552 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-381472
Source: Form D, filed Nov 25, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas Nelson | Executive |
| Gene Ruffner Page | Director |
| George B Salem | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1500 Urban Center Drive Suite 530
Birmingham, AL, 35242
Birmingham, AL, 35242